Immunocore Holdings plc (IMCR) reported Q3 EPS of ($0.14), $0.10 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $45.87 million versus the consensus estimate of $32.82 million.
Immunocore Holdings plc (IMCR) reported Q3 EPS of ($0.14), $0.10 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $45.87 million versus the consensus estimate of $32.82 million.